are characterized by the loss of expression of numerous genes, suggesting that Myc may also exert a negative The c-Myc protein activates transcription as part of function on gene expression. Genes that are repressed in a heteromeric complex with Max. However, MycMyc-transformed cells encode, for example, cell surface transformed cells are characterized by loss of expresproteins involved in cell adhesion (e.g. Judware and Culp, sion of several genes, suggesting that Myc may also 1995) and interaction of cells with the immune system repress gene expression. Two-hybrid cloning identifies (e.g. Bernards et al., 1986; Versteeg et al., 1988 ; Inghirami a novel POZ domain Zn finger protein (Miz-1; Mycet al., 1990) , and cell cycle regulators like c/EBP-α interacting Zn finger protein-1) that specifically inter- (Freytag and Geddes, 1992) , cyclin D1 (Philipp et al. , acts with Myc, but not with Max or USF. Miz-1 binds 1994) and c-myc itself (Penn et al., 1990) . The findings to start sites of the adenovirus major late and cyclin suggest that gene repression contributes significantly to D1 promoters and activates transcription from both the phenotype of Myc-transformed cells. promoters. Miz-1 has a potent growth arrest function.
Loss of expression of certain genes may be an indirect Binding of Myc to Miz-1 requires the helix-loop-helix consequence of the transformed state and thus be an domain of Myc and a short amphipathic helix located indirect consequence of transcriptional activation by the in the carboxy-terminus of Miz-1.
Expression of Myc
Myc-Max complex. However, several observations indiinhibits transactivation, overcomes Miz-1-induced cate that this is not the case. First, for both the adenovirus growth arrest and renders Miz-1 insoluble in vivo.
major late (AdML) and the c/EBP-α promoter, specific These processes depend on Myc and Miz-1 association sequence determinants have been identified that are and on the integrity of the POZ domain of Miz-1, required for repression by Myc. In both cases, these suggesting that Myc binding activates a latent inhibielements are localized close to the start site of transcription tory function of this domain. Fusion of a nuclear and differ from the E-box elements recognized by Myclocalization signal induces efficient nuclear transport Max complexes (Li et al., 1994) . Second, an analysis of of Miz-1 and impairs the ability of Myc to overcome mutant alleles of Myc for repression of cyclin D1 exprestranscriptional activation and growth arrest by Miz-1.
sion in vivo identified alleles of Myc that were capable of Our data suggest a model for how gene repression by repression, but not transactivation; some of these alleles Myc may occur in vivo.
Introduction
ments revealed that repression of the endogenous c-myc gene after induction of conditional alleles of Myc is c-myc was identified as the cellular homologue of the an early response and precedes the appearance of the transforming oncogene of the avian retroviruses MC29, transformed phenotype (Facchini et al., 1997) . OK10, MH2 and FH3; it encodes a central regulator of
These observations prompted us to search for proteins mammalian cell proliferation and apoptosis (for review, that may mediate gene repression by Myc. We now report see Henriksson and Lüscher, 1996) . the identification of one such protein by two-hybrid Myc protein is a helix-loop-helix/leucine zipper (HLH/ cloning. We call this protein Miz-1 (for Myc-interacting LZ) protein that binds specifically to DNA and recognizes zinc finger protein). Miz-1 is a zinc finger/POZ (BTB) CAC(A/G)TG elements (Blackwell et al., 1990;  domain protein (Bardwell and Treisman, 1994; Albagli Prendergast and Ziff, 1991) . In vivo, Myc forms heteroet al., 1995; Chen et al., 1995) . In contrast to other POZ dimers with a second HLH/LZ protein termed Max domain proteins, Miz-1 is a soluble protein that binds to . Binding to Max is a prerequisite for transformation by and transactivates the AdML and cyclin D1 promoters.
Association with Myc induces nuclear sequestration and other. To test this prediction, we deleted amino acids 641-715 of Miz-1; this deletion abolished interaction with Myc renders Miz-1 insoluble, characteristic features of POZ domain proteins; a mutant of Miz-1 that lacks the POZ in the two-hybrid assay ( Figure 1E ). A smaller deletion of amino acids 683-715 strongly inhibited association of domain is largely unaffected by Myc. The data suggest a model in which Myc inhibits gene transcription by inducMiz-1 with Myc. To test whether these amino acids interact with Myc as part of a helical structure, we ing the inhibitory functions of the Miz-1 POZ domain.
constructed two further mutants of Miz-1: one in which five hydrophobic amino acids within the putative helical
Results
segment were replaced either by prolines or by a glycine (L695P, I699P, A702P, V703G, V706P; designated '4 Previous work had shown that the integrity of the HLH domain of Myc was critical for gene repression by Myc
Pro') and a second mutant in which Ile699 was replaced by proline and Ser700 by glycine (I699P, S700G; desigin stable cell lines (Philipp et al., 1994) and in transient transfection assays (A.Schneider, unpublished; see below) .
nated '1 Pro'). The '4 Pro' mutant of Miz-1 did not interact with Myc in the two-hybrid assay; interaction To identify novel proteins that interact with the carboxyterminus of Myc, a DNA fragment encoding the basic between the '1 Pro' mutant of Miz-1 and Myc was reduced Ͼ10-fold relative to wild-type Miz-1 ( Figure 1E ). Taken region and the HLH/LZ domain (amino acids 355-439 of human Myc) was fused in-frame to the DNA-binding together, the data show that amino acids located between zinc fingers 12 and 13 of Miz-1 are required for interaction domain of GAL4 (amino acids 1-147) and used as a bait in a two-hybrid screen (Fields and Song, 1989) . A total with Myc in the two-hybrid assay and suggest that they interact as part of an α-helix. of 2ϫ10 5 independent transformants of a HeLa cell cDNA library tagged with the GAL4 activation domain were Two experiments were designed to confirm the specific association between Miz-1 and Myc. First, amino acids screened. One clone that conferred β-galactosidase activity was characterized further ( Figure 1A ). No interaction was 269-803 of Miz-1 were fused to glutathione-S-transferase (GST) and the GST-Miz-1 fusion protein was purified detected between the protein encoded by this clone and either the DNA-binding domain of GAL4 alone or a and incubated with in vitro synthesized, radiolabelled Myc protein ( Figure 2A ). Myc associated with GST-Miz-1 but GAL4-BCY-1 chimera used as a negative control. Interaction with Myc was abolished by deletion of the HLH not GST; a mutant allele of Myc lacking the HLH domain bound significantly less well to GST-Miz-1, although a domain (Δ370-412) in Myc, but not by the insertion of four amino acids between the HLH domain and the leucine low level of residual binding was detectable in vitro. Radiolabelled Max interacted neither with GST-Miz-1 zipper (In412) or by the deletion of the entire leucine zipper (Δ412-434). A specific interaction was also detected nor with GST.
To show further that Myc and Miz-1 interact in vivo, a with N-Myc, but not with Max or USF, two HLH proteins closely related to Myc ( Figure 1B ). We concluded that polyclonal antibody was raised against a His-tagged protein encompassing amino acids 269-803 of Miz-1. This we had identified a protein that specifically interacts with the HLH domain of both c-and N-Myc.
antibody specifically recognized recombinant Miz-1 in Escherichia coli extracts (data not shown), full-length Full-length cDNA molecules were isolated using a 5Ј-RACE protocol and sequenced; they encode a protein of Miz-1 after expression in HeLa cells ( Figure 6A ) and a protein of the expected molecular weight in extracts of 803 amino acids with a predicted mol. wt of 87 970 Da ( Figure 1C ). Sequencing revealed that the clone we had HeLa cells (see Figure 7A ). HeLa cells were co-transfected with expression vectors encoding either Myc or full-length isolated encoded a zinc finger protein with 13 zinc fingers, 12 of which are immediately clustered in the carboxyMiz-1. Lysates were prepared by sonication in buffer containing non-ionic detergents, clarified by centrifugation terminal half of the protein. We will refer to this protein as Miz-1 (Myc-interacting zinc finger protein). At its and pre-absorption to protein G-Sepharose and precipitated with either pre-immune or anti-Miz-1 antibody. amino-terminus, Miz-1 carries a BTB/POZ domain, which has been identified as a negative regulatory domain (see Precipitates were washed extensively, separated by SDS-PAGE, blotted and probed with a monoclonal antibody below) (Bardwell and Treisman, 1994) . A closely related murine cDNA has been isolated (Schulz et al., 1995) ; the directed against human Myc. Myc was detected in antiMiz-1, but not control immunoprecipitates ( Figure 2B ). encoded mouse and human proteins are 92% identical over their entire length. The clone obtained in the twoIn the inverse experiment, polyclonal antibodies against Miz-1 detected the protein in precipitates with an antihybrid screens encodes amino acids 269-803 of the fulllength Miz-1 protein. A series of deletion mutants was Myc monoclonal antibody, but not in control precipitates with the same amount of an irrelevant control antibody used to localize further the domain of Miz-1 that interacts with Myc ( Figure 1D ). The results define two regions ( Figure 2B ). We concluded that Myc and Miz-1 associate in vivo. In these experiments,~2% of the transfected flanking the central 12 zinc fingers of Miz-1 that are required for interaction with Myc, as deletion of either Miz-1 was found complexed with Myc; however, the experiment shown in Figure 6A demonstrates that the low amino acids 269-308 or 637-718 of Miz-1 abolishes interaction in the two-hybrid assay.
salt conditions required for immune precipitation strongly favour solubilization of free Miz-1, as the Miz-Myc Structure prediction programs predict that amino acids located between zinc fingers 12 and 13 of Miz-1 have a complex is poorly soluble in low salt buffers. Data shown in Figure 6 further suggest that most Miz-1 protein high propensity to form an amphipathic α-helix (see Figure 1E ) (Lupas et al., 1991) . As the HLH motif domain expressed in cells associates with Myc under the experimental conditions. The low abundance of both proteins has a similar structure (Ferré D'Amaré et al., 1993) , it seemed conceivable that both domains interact with each and the inability to detect Miz-1 by labelling with [ 35 S]-methionine or [ 32 P]phosphate in non-transfected cells have independently in a screen for proteins that bind to the major start site of the TATA-less polyoma virus major so far precluded attempts to demonstrate association of the endogenous proteins.
late promoter (L. Rapp and G.Carmichael, submitted) . To test whether Miz-1 interacts with related sequences at the The murine homologue of Miz-1 has been identified start site of the AdML promoter, electrophoretic mobility transactivated by Miz-1, suggesting that binding of Miz-1 to the AdML promoter is required for activation (Figure shift experiments were performed with purified recombinant Miz-1 and 32 P-labelled oligonucleotides spanning the 3B). Also, a mutant of Miz-1 that lacked zinc fingers 1-12 (Δ309-636) activated the AdML promoter inefficiently, polyoma virus major late promoter start site ( Figure 3A) . Binding of recombinant Miz-1 was easily detectable; further suggesting that DNA binding by Miz-1 is required for full activation ( Figure 3C ). supershifting with specific antibodies confirmed that the shifted band contained Miz-1 protein. Binding of Miz-1
We wondered whether Myc affected transactivation by Miz-1 and repeated these experiments in the presence of was specific as it was competed by a 100-fold excess of an oligonucleotide spanning the polyoma major late a constant amount of a CMV-Myc expression vector. Expression of Myc did not interfere with the basal activity promoter transcription start site, but not by a mutated, non-functional derivative (L. Rapp and G.Carmichael, sub- of the AdML promoter in HeLa cells ( Figure 4A ) nor with expression of Miz-1 (data not shown). However, mitted). Binding was also competed by a similar molar excess of oligonucleotides derived from the AdML start expression of Myc significantly impaired transactivation of the AdML promoter by Miz-1 ( Figure 4A ). site, but not by a mutated derivative (for sequences, see Materials and methods). In similar experiments, a specific Two controls showed that complex formation between Miz-1 and Myc was required for inhibition of transactivinteraction of Miz-1 with the major start site of the human cyclin D1 promoter was detected (see below). No ation. First, a mutant allele of Myc that lacks the HLH domain and failed to interact with Miz-1 also failed to interaction of Miz-1 was detected with the E-box element of the prothymosin-α intron, which is a target for transinhibit Miz-1 function although it was expressed at the same level as the wild-type protein ( Figure 4A ). Transactivation by Myc (Desbarats et al., 1996) .
To test whether Miz-1 affects expression of the AdML activation by Miz-1 was abolished by expression of In412Myc, a mutant of Myc that fails to bind Max and promoter, transient transfection experiments were performed in which increasing amounts of cytomegalovirus to transform cells yet interacts with Miz-1 (see Figure  1A ) and is capable of repression in vivo (Philipp et al., (CMV) -Miz-1 plasmid were co-transfected with an AdML reporter plasmid into HeLa cells ( Figure 3B ). Sequences 1994); a complete deletion of the leucine zipper of Myc (Δ412-434) had a partial effect on inhibition (data not contained in this reporter span from -45 to ϩ65 nucleotides relative to the major start site and do not encompass the shown). Second, transactivation of the AdML promoter by a deletion mutant of Miz-1 (Δ641-715) that failed to E-box element located 60 nucleotides upstream of the major start site. As a control for transfection efficiency, a interact with Myc in the two-hybrid assay was resistant to inhibition by Myc ( Figure 4B ). The data show that CMV-lacZ plasmid was co-transfected. Expression of Miz-1 transactivated the AdML promoter, and maximal complex formation between Miz-1 and Myc is required for inhibition of transactivation by Miz-1. activation was 10-fold relative to the CMV-lacZ control. Similar results were obtained in QT6 cells (not shown).
To test whether binding of Myc to Miz-1 was not only necessary, but also sufficient for inhibition, we expressed A derivative of the AdML promoter which contains a mutated start site (kind gift of B.Roeder) was poorly the GAL4-Myc(355-439) fusion protein used as a bait in domain of Myc, precluding the possibility that inhibition of transactivation is due to squelching of the transactivation domain of Miz-1. To support this notion further, we fused related to Myc (Littlewood et al., 1992) . In contrast to Myc, USF activates transcription of the AdML, c/EBPα the potent transactivation domain of the viral transactivator VP16 to Miz-1. VP16-Miz-1 chimeras strongly transactivand cyclin D1 promoters (Phelps et al., 1988; Du et al., 1993; Li et al., 1994; Philipp et al., 1994) . To test ated the AdML promoter and transactivation was sensitive to inhibition by GAL-Myc ( Figure 4B ). The data show whether USF affected transactivation by Miz-1, transient transfection experiments were performed as before with that Myc does not inhibit Miz-1 function by squelching its transactivation domain.
a CMV-USF expression vector. Both USF and Miz-1 transactivated the AdML promoter; together, there was an Surprisingly, both Miz-1ΔPOZ and a VP16-Miz-1ΔPOZ chimera that lack the amino-terminal POZ domain of additive effect on the AdML promoter and no sign of either mutual inhibition or synergistic activation could be Miz-1 were poorly inhibited by expression of GAL-Myc ( Figure 4C ), although transactivation by either protein in detected ( Figure 4D ). This is consistent with the lack of interaction between USF and Miz-1 in the yeast twothe absence of Myc was less potent than that of the corresponding wild-type allele of Miz-1. The POZ domain hybrid assay ( Figure 1B) . Similarly, Max failed to interact with Miz-1 in two-hybrid assays. By itself, Max did not is not required for interaction with Myc either in the twohybrid assay or in vitro. Thus, association between Miz-1 affect expression of the AdML promoter and did not affect transactivation of the AdML promoter by Miz-1 (Figure and Myc is required, but not sufficient for full inhibition of Miz-1 function. In addition, inhibition of Miz-1 function 4D). We concluded from these experiments that interaction with and inhibition of Miz-1 is specific for Myc. by Myc requires the integrity of the amino-terminal POZ domain of Miz-1.
Both Max and Miz-1 interact with the HLH domain of Myc; thus, Max might compete with Miz-1 for complex In vivo, cells transformed by Myc contain high amounts of both USF and Max, HLH/LZ proteins that are closely formation with Myc. Two experiments were set up to address this question in vivo. First, we tested whether we made use of the observation that Myc and Max synergistically activate the prothymosin-α enhancer ectopic expression of Miz-1 influenced transactivation by Myc and Max from an E-box-TATA construct; to do this, (Desbarats et al., 1996) . We observed a 5-fold activation of a ProT-Luc reporter plasmid by Myc and Max in the absence of Miz-1; including up to 10 μg of CMV-Miz-1 vector did not affect activation by Myc and Max ( Figure  4E ). We concluded that either formation of a ternary MycMiz-1-Max complex is possible or that the affinity of Miz-1 for Myc is not high enough to disrupt a Myc-Max complex under the experimental conditions. To test the latter possibility, we analysed the effect of Max on the inhibition of Miz-1 function by Myc. We observed that Max partly reversed Myc-mediated inhibition of Miz-1 ( Figure 4F ), suggesting that Max and Miz-1 may form alternate complexes with Myc in vivo. This is also suggested by data on the intracellular localization of Miz-1 (see Figure 6 ). In order to identify potential cellular target genes for Miz-1 transactivation, we turned to the cyclin D1 promoter which is repressed by Myc in a Max-independent fashion (Philipp et al., 1994) . The cyclin D1 promoter contains four E-boxes upstream of the TATA-less start site and might thus be a target for both activation and repression by Myc (see Figure 5B) . Indeed, the response in cyclin D1 mRNA levels to ectopic expression of Myc is strongly affected by the genetic background of a cell (Marhin et al., 1996) .
Gel-shift assays showed that Miz-1 specifically interacts with the major start site of the human cyclin D1 promoter (Herber et al., 1994) , but not with a minor start site located 80 bp further upstream (Philipp et al., 1994) ( Figure 5A ). For transient transfections, a cyclin D1 reporter plasmid containing both start sites and the upstream E-box elements was used as reporter ( Figure 5B ). In the absence of Miz-1, Myc transactivated expression of cyclin D1 at low levels of expression and inhibited at higher expression levels ( Figure 5C ); similar responses have been reported for the full-length AdML promoter, which also contains both an E-box and an Inr element (Li et al., 1994) . Ectopic expression of Miz-1 activated the reporter 4-fold (not shown). Very little activation of the cyclin D1 promoter by Myc was observed in the presence foci and to inhibit DNA binding of the attached zinc fingers and transcriptional activation in vivo (e.g. Bardwell and Treisman, 1994; Dhordain et al., 1995) . POZ domain and found that~20% of nuclear Miz-1 protein was soluble in buffer containing 200 mM NaCl, and Ͼ80% soluble in proteins are usually insoluble under conditions that are used to solubilize transcription factors. This is also true the presence of 420 mM NaCl ( Figure 6A ). Second, immunofluorescence of transfected HeLa cells showed a for the endogenous proteins, demonstrating that it is not an artefact caused by overexpression (Dhordain et al., homogeneous staining of Miz-1 within the nuclei, with no sign of aggregation or clustering ( Figure 6B ). Thus, 1995); therefore, the POZ domain appears to act as a negative regulatory domain for transcription factor either the physical properties of the Miz-1 POZ domain differ from those of other POZ domains or its activity is function.
Two experiments were set up to test whether this applies masked within the context of the whole protein.
We wondered whether association with Myc affected to Miz-1. First, we fractionated transfected HeLa cells this behaviour, and thus we repeated fractionation and expressed the Miz-1ΔPOZ mutant either alone or together with Myc. Upon fractionation, Miz-1ΔPOZ was fully immunofluorescence in the presence of Myc. Upon coexpression of Myc, Miz-1 protein was completely insoluble soluble at 420 mM salt both in the presence and absence of Myc ( Figure 6A) ; immunofluorescence experiments at 200 mM and Ͼ90% insoluble at 420 mM NaCl ( Figure  6A ). Also, Miz-1 localized in a number of discrete, showed no sign of co-aggregation of Myc and Miz-1ΔPOZ ( Figure 6B ). subnuclear foci identical to what is observed for other POZ/BTB domain proteins ( Figure 6B ). Judged by 4Ј,6Ј-The data show that complex formation with Myc alters the physical properties of Miz-1 in vivo and renders diamidino-2-phenylindole (DAPI) staining, these foci are free of DNA. Co-staining with antibodies directed against the protein insoluble in the nucleus. Like inhibition, sequestration depends on association of Myc with Miz-1 Myc showed co-localization of Myc and Miz-1 within the nucleus ( Figure 6B ). This 'sequestration' of Miz-1 and requires the integrity of the Miz-1 POZ domain. Most probably, therefore, sequestration of Miz-1 by Myc depended on the HLH domain of Myc, demonstrating that Myc needs to interact with Miz-1 to induce sequestration accounts for the functional inhibition of transactivation, and association with Myc induces the normally latent ( Figure 6B ). Myc proteins previously have been shown to aggregate activity of the Miz-1 POZ domain. The data also suggest that most Miz-1 protein associates with Myc in these cells. easily upon extraction (e.g. Evan and Hancock, 1985) ; thus Miz-1 might be dragged into such complexes in It is apparent from the data that only a fraction of Miz-1 was translocated into the nucleus in the absence of Myc, a non-specific manner. To exclude this possibility, we whereas all Miz-1 was detected in the nucleus in the lines, suggesting that Miz-1 inhibits cell growth. Similarly, no colonies could be established after infection of either presence of Myc (Figure 6A and B; a quantitation is shown in C). In the absence of Myc, a significant proportion of RAT1A (not shown) or Balb/c-3T3 cells ( Figure 8E ) with a recombinant retrovirus expressing Miz-1. cells showed strong cytosolic staining, with only some protein localized in the cell nucleus; this was even more Suppression of growth may be due to inhibition of cell proliferation, induction of apoptosis or both. Visual pronounced for a mutant Miz-1 protein lacking the POZ domain. In the presence of Myc, most cells expressing inspection of HeLa cells transfected with a Miz-1 vector together with a resistance marker revealed a number of Miz-1 showed an exclusively nuclear staining of Miz-1. Expression of Myc did not affect the subcellular localizsingle large cells after selection, suggesting that Miz-1 inhibits proliferation. To demonstrate this formally, we ation of mutants of Miz-1 that lack the POZ domain; indeed, such mutants acted as partial dominant-negative transfected HeLa cells transiently and determined the percentage of cells expressing Miz-1 that progressed into alleles for nuclear import of Myc and led to a retention of Myc protein in the cytosol ( Figure 6C) . Expression of mitosis. To prevent further cell cycle progression, taxol was added for 18 h before harvesting. Expression of either Max increased the frequency of cytosolic wild-type Miz-1, supporting the notion that Max and Miz-1 compete for GFP or β-galactosidase did not affect progression into mitosis ( Figure 8B and data not shown). Upon expression binding to Myc ( Figure 6C ). The data suggest that Myc and Miz-1 proteins are co-imported into the nucleus under of Miz-1, the total number of transfected cells was unaltered (not shown); however, few cells expressing the experimental conditions. Why is nuclear import of Miz-1 inefficient in the Miz-1 progressed into mitosis ( Figure 8B ). We concluded that Miz-1 inhibits cell cycle progression of HeLa cells. absence of Myc? It is possible that this is an artefact due to the high expression levels achieved upon transient
To determine at which point in the cell cycle arrest occurs, we co-transfected an expression plasmid encoding transfection. To exclude this possibility, we fractionated non-transfected HeLa cells and determined the distribution Miz-1 together with a plasmid encoding the surface protein CD20, which allows the identification of transfected cells of endogenous Miz-1 by Western blotting ( Figure 7A) . Most of the endogenous Miz-1 co-fractionated with the in a fluorescence-activated cell sorting (FACS) experiment. Staining of transfected HeLa cells for DNA showed that cytosolic marker protein, β-tubulin, similar to what was found for the transfected protein. A small amount was cells expressing Miz-1 accumulated in the S-phase of the cell cycle, both in the absence and presence of taxol contained in the nucleus and was insoluble in the presence of 420 mM NaCl, suggesting that it may be sequestered ( Figure 8C ). Thus, expression of Miz-1 in HeLa cells allows progression into S-phase, but not into mitosis; by Myc. Thus both endogenous and transfected proteins show a similar subcellular distribution.
whether the failure of HeLa cells to arrest in G 1 is due to the presence of the papillomavirus E6 and E7 proteins Next, we tested whether Miz-1 contains a nuclear localization signal (NLS). Inspection of the Miz-1 remains to be determined. A series of mutants of Miz-1 was used to determine sequence revealed a single weak homology to a consensus NLS, located at amino acids 370-374. However, fusion which domains of Miz-1 were required for inhibition. Both Miz-1 and NLS-Miz-1 were equally efficient at of amino acids 360-380 to green fluorescent protein failed to target the protein to the nucleus, suggesting that Miz-1 inhibiting cell cycle progression, suggesting that arrest by Miz-1 occurs in the cell nucleus ( Figure 8B ). Deletion of may lack an NLS (data not shown). To test this notion directly, we fused the SV40 large-T NLS to the aminozinc fingers 1-12 abolished cell cycle arrest by Miz-1, demonstrating that binding of Miz-1 to DNA is necessary. terminus of Miz-1 and found that the resulting chimera (NLS-Miz-1) was localized exclusively in the nucleus Deletion of the POZ domain somewhat diminished, but did not abolish cell cycle arrest; this is similar to the even in the absence of co-expressed Myc ( Figure 7B ). Most probably, therefore, Miz-1 lacks a functional NLS.
effects of this mutant in transactivation. Taken together, the data are explained most easily by the notion that We hypothesized that the lack of an NLS might serve to limit the amount of Miz-1 in the nucleus and might arrest of cell cycle progression by Miz-1 occurs by transactivation of a set of Miz-1 target genes. thus lower the amount of Myc required to inhibit Miz-1 in vivo. To support this hypothesis, we tested whether Two experiments were set up to test whether Myc affects cell cycle arrest by Miz-1. First, a number of Myc was able to inhibit transactivation by NLS-Miz-1 ( Figure 7B ). As before, ectopic expression of Myc efficimutants of Miz-1 that are deficient in interaction with Myc (see Figure 1E ) were tested for their ability to arrest ently inhibited transactivation by wild-type Miz-1 protein.
In contrast, Myc was inefficient at inhibiting transactivproliferation of HeLa cells (which express high levels of Myc) ( Figure 8B ). All mutants efficiently induced cell ation by NLS-Miz-1 ( Figure 7B ). Titration experiments showed that this lack of inhibition was not due to a failure cycle arrest, demonstrating that arrest by Miz-1 does not depend on association with Myc. Significantly, all four of Myc to interact with NLS-Miz-1: when low amounts of Miz-1 or NLS-Miz-1 were used to activate transcription, mutants were up to 10-fold (Δ641-715) more effective than wild-type Miz-1 in arresting HeLa cell proliferation. expression of high amounts of Myc could indeed inhibit transactivation by both Miz-1 and NLS-Miz-1 ( Figure 7B ).
The data strongly suggest that association with endogenous Myc relieves cell cycle arrest by Miz-1. To gain insight into the biological function of Miz-1, we expressed the protein together with a hygromycin Ectopic expression of Myc in HeLa cells efficiently induced apoptosis in the presence of taxol; thus, we could resistance plasmid by transient transfection in both NIH 3T3 and HeLa cells. After selection, the number of not determine whether Myc overcomes a Miz-1-dependent cell cycle arrest in this assay. Therefore, we performed resistant colonies was determined ( Figure 8A ). Expression of Miz-1 strongly inhibited colony formation of both cell colony formation assays in NIH 3T3 cells in the presence or absence of Myc and observed that ectopic expression expression of Myc can partly overcome a cell cycle arrest by Miz-1; they strongly suggest that this is at least in part of Myc partly relieved growth suppression by Miz-1 ( Figure 8D ). In this assay, Myc was unable to relieve the due to association with Miz-1 and interference with Miz-1-dependent transactivation by Myc. arrest induced by either NLS-Miz-1 or Miz-1ΔPOZ, similar to what is observed for transactivation ( Figure  We were concerned that both arrest by Miz-1 and its relief by Myc might be restricted to the very high 8D). Further, mutants of Miz-1 that fail to interact with Myc in the two-hybrid assay were more resistant to rescue expression levels achieved with CMV-derived vectors. Therefore, we infected both RAT1A and Balb/c-3T3 cells by Myc (Figure 8D ), although the effects were not as strong as in HeLa cells. The data show that ectopic with a recombinant retrovirus expressing Miz-1 together Cells were sorted into CD20 negative and positive populations and the cell cycle distribution determined by staining with propidium iodide (Rudolph et al., 1996) . ( Enhanced expression of c-myc is observed in many human tumours and causally contributes to tumorigenesis. One colony formation in the presence of Miz-1; the resulting colonies, however, grew more slowly than control cells mechanism by which Myc transforms cells has been clearly defined: Myc forms a heteromeric complex with its ( Figure 8E ). Western blotting revealed that the growing cells expressed Miz-1 protein ( Figure 8E ).
partner protein Max that binds to and activates transcription from CACGTG sequences (see Introduction). Binding to Our data show that Miz-1 exerts a strong growthsuppressive effect in the cell nucleus and that growth Max is a prerequisite for transformation by Myc, and at least two of the known target genes of the Myc-Max arrest by Miz-1 is alleviated by Myc. Alleles of Miz-1 that lack the POZ domain, are constitutively localized in complex, ODC and cdc25A, have transforming potential by themselves (Auvinen et al., 1992; Amati et al., 1993b ; the nucleus or are deficient in interaction with Myc are all more potent than wild-type Miz-1 in arresting the Galaktionov et al., 1995) . The findings strongly suggest that Myc exerts its transforming function at least in part transformed by Myc (Berberich and Cole, 1992; Littlewood et al., 1992) , and repression by Myc occurs in by activating transcription of a critical set of cellular target genes.
the presence of an excess of these proteins. Neither USF nor Max repress either the AdML or the cyclin D1 A similar argument can be made for gene repression by Myc. Genes that are repressed in Myc-transformed promoters (Li et al., 1994; Philipp et al., 1994 presence of an excess of closely related transcription factors. Myc interferes with the function of CCAAT-binding transcription factors, potentially by inducing the phosphorylFourth, our observations suggest a potential mechanism as to how gene repression by Myc may occur. The POZ ation of these proteins (Yang et al., 1991) . Viral Myc has been shown to squelch the transcriptional activation domain has been shown to target transcription factors to discrete subnuclear foci in vivo and render the proteins domain of c/EBP, a transcription factor involved in cellular differentiation (Mink et al., 1996) . Also, direct interactions insoluble upon extraction (e.g. Dhordain et al., 1995) . The POZ domain of the ZID protein inhibits both DNA have been reported between Myc and either YY-1 or TFII-I, two proteins that can interact with initiator elements binding by the zinc fingers and transcriptional activation, potentially by inducing homodimerization of ZID and may be part of the basal transcription machinery (Roy et al., 1993; Shrivastava et al., 1993) . (Bardwell and Treisman, 1994 In vivo, Miz-1 has a potent growth arrest function in several rodent and human cell lines. The arrest exerted gene repression in vivo. In contrast, the requirement for the leucine zipper was much less pronounced. In particular, by different alleles of Miz-1 correlates closely with their ability to transactivate transcription. Most likely, therefore, a mutation (In412) that inserts four amino acids between the HLH domains and the leucine zipper is fully competent arrest by Miz-1 occurs via the transcriptional activation of a set of growth-inhibitory genes. Although the critical for repression in vivo, yet fails to interact with Max and is transformation deficient (Philipp et al., 1994) . The target genes for this arrest function are unknown, it is noteworthy that ectopic expression of cyclin D1 can arrest association between Miz-1 and Myc provides a rationale for these observations, as Miz-1 interacts with the HLH cells during S-phase of the cell cycle (Pagano et al., 1994) , suggesting that cyclin D1 may play a role in the domain, but not the leucine zipper of Myc. Further, these findings provide an explanation as to why repression can Miz-1-dependent growth arrest. A requirement for Myc function late in the cell cycle (during S-and G2-phase) be hormone independent in MycER chimeras (Philipp et al., 1994) . As the attached hormone-binding domain is has been demonstrated in B-cells (Shibuya et al., 1992) . We have not obtained any evidence that arrest of thought to act by simple steric hindrance (Picard et al., 1988) , the simplest explanation is that it sterically interproliferation by Miz-1 occurs via inhibition of transcriptional activation by Myc. In particular, alleles of Miz-1 feres with protein-protein interactions of the leucine zipper, but not in the HLH domain, which extends in a that fail to interact with Myc in the two-hybrid assay are capable of arrest and are more potent than wild-type Miz-1 linear way away from the leucine zipper (Ferré D'Amaré et al., 1993) .
in arresting proliferation. These findings place Miz-1 in a growth control pathway downstream of Myc. However, Second, sequences close to the start site of transcription have been shown to determine the extent to which the previous work has shown that induction of cell proliferation, like all known biological effects of Myc, requires AdML and the c/EBPα promoters are repressed by Myc (Li et al., 1994) . In addition, a number of genes that are association with Max. In particular, mutations of Myc that render the leucine zipper of Myc unable to interact with repressed by Myc in vivo are encoded by TATA-less promoters with defined start sites, suggesting that they use Max are biologically inactive; they can be complemented by corresponding mutations in the leucine zipper of Max initiator elements. We have shown that Miz-1 specifically interacts with sequences at the start site of the AdML and (Amati et al., 1993a,b) . The data show that association of Myc with Max is required for Myc to be active, and the cyclin D1 promoter (Figures 3 and 5) . Mutation of these sequences or deletion of the zinc fingers inhibits strongly suggest that Max is the only required partner protein for the leucine zipper of Myc. transcriptional activation of the AdML promoter by Miz-1. Thus, interaction of Myc with Miz-1 can explain the Our data do not question this concept for a number of reasons. First, Miz-1 interacts with the HLH domain, not specificity of repression that is observed in vivo.
Third, interaction with Miz-1 reflects the specificity the leucine zipper of Myc ( Figure 1A) . Second, the effects of ectopic expression of Max on the interaction of Miz-1 seen for gene repression by HLH proteins. Both USF and Max are more abundant than Myc in cells that are with Myc in vivo are relatively small (see, for example, Figure 4E ). While they suggest that Myc-Max and Myccarcinoma, two tumours in which alterations at myc gene loci are well documented and play an important role. Miz-1 form alternative complexes in vivo, they are also compatible with the notion that ternary Myc-Max-Miz-1 complexes form but are less stable than binary Myc- protein's function by association must explain how the The mutant alleles of Myc used have been described (Stone et al., 1987 excised and inserted into pXP1 luc (Nordeen, 1988) . The wild-type
Materials and methods
In the presence of high amounts of Myc protein, reporter constructs contain a major (-9 to ϩ10: 5Ј-TTCGTCCTCACTCTassociation with Myc itself provides an NLS to Miz-1.
CTTCC-3Ј) and a minor (ϩ37 to ϩ59: 5Ј-TTGGGGTGAGTACTCCWhether Myc contributes significantly to nuclear import CTCTGAA-3Ј) transcription start site. The mutated reporter constructs of Miz-1 at physiological concentrations remains to be contain the following sequences: (-9 to ϩ10: 5Ј-TTCGACGGCAC-AAACTTCC-3Ј), (-39 to ϩ59: 5Ј-TTGGGCTGACTGCTCCGGCAdetermined. As Miz-1 arrests proliferation in the nucleus, . The CMV-Myc, CMV-MycΔHLH, CMV-USF and CMV-Max it seems likely that other proteins interacting with Miz-1 constructs have been described (Philipp et al., 1994; Desbarats et al., may also provide NLSs and regulate the amount of Miz-1 1996). To generate CMV-Miz-1 wt, CMV-Miz-1ΔPOZ, CMV-NLSin the cell nucleus. In this sense, stimulation of nuclear Miz-1 and CMV-NLS-ΔPOZ-Miz-1, PCR was used to amplify either full-length Miz-1 or a ΔPOZ derivative (amino acids 105-803); the import of Miz-1 by Myc may be reminiscent of that of corresponding fragments were inserted into the EcoRI and XbaI sites of E2F-4, which also lacks a nuclear import signal. Import pUHD 10.1.
of E2F-4 is stimulated by association with either p107 or
To generate recombinant retroviruses, Miz-1 cDNA was inserted into p130, pocket proteins that negatively regulate E2F-4 pbabe-hygro (Morgenstern and Land, 1990) ; generation of viruses and function in vivo (Lindeman et al., 1997) .
infection of cells were carried out according to Pear et al. (1993) . Transient transfection experiments were performed as described
In several experiments, we observed that cytosolic previously (Desbarats et al., 1996) .
Miz-1 associates with microtubuli (see, for example, Figure 7B ) and indeed can target a Gal-Myc chimera to
Gel-shift experiments microtubuli (data not shown). If mechanisms exist that
To express recombinant Miz-1 protein, a cDNA fragment encoding stabilize association of Miz-1 with microtubuli, it is also amino acids 269-803 was cloned into a bacterial expression vector conceivable that Miz-1 can be an upstream regulator of (pRSET) that supplies an N-terminal cassette of six histidines; the fusion protein was purified by affinity chromatography on an Ni 2ϩ -Sepharose Myc function by regulating nuclear import of Myc. In vivo, column (Qiagen, Hilden, Germany). Binding was carried out for 10 min high expression of Miz-1 is observed in brain, in muscle at room temperature in 50 mM MgCl 2 , 10 mM dithiothreitol (DTT), and in several myeloid cell lines (A.Schneider, unpub-10 mM EDTA, 10 mM ZnCl 2 , 100 mM Tris pH 7.5.
lished). Nuclear import of Myc is blocked in differentiating
Oligonucleotides were used as follows: polyoma, 5Ј-TTGACATTTT-CTATTTTAAGAGTCGGGAGGAAAATTA-3Ј; polyoma mut, 5Ј-TTGmyeloid and neuronal cells, and both cells accumulate ACATTTAGTCGGGAGGAAAATTA-3Ј; cyclin D1 -22/ϩ22, 5Ј-AGTeither c-or N-Myc protein in the cytosol (Craig et al., TTTGGTGAAGTTGCAAAGTCCTGGAGCCTCCAGAGGGCTGT-1993; Wakamatsu et al., 1993) . In HeLa and HL6o cells, in vitro (Alexandrova et al., 1995) . Thus, the association of Myc and Miz-1 with microtubuli may be stable in Protein-binding assays differentiating cells and then serve as a cytosolic anchor
In vitro. Transcription/translation was carried out in reticulocyte lysate for both Miz-1 and Myc.
(Promega) according to the manufacturer's protocol. Twenty μg of Finally, we note the recent localization of a fragment affinity-purified GST fusion protein was bound to 100 μl of glutathioneof Miz-1 to 1p36.1-1p36.2 (Tommerup and Vissing, 1995) . agarose (100 μg/ml) (Sigma) in the presence of 20 mM HEPES pH 7.8, 100 mM KCl, 5 mM MgCl 2 . To assay for specific interactions, 10 μl This localization was confirmed using the entire human 1996). Among them are both neuroblastoma and colon
